Learn About Chondrodystrophy
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Peter Smith is an Orthopedics provider in Chicago, Illinois. Dr. Smith and is rated as an Advanced provider by MediFind in the treatment of Chondrodystrophy. His top areas of expertise are Osteogenesis Imperfecta, Clubfoot, Schwartz-Jampel Syndrome, and X-Linked Spondyloepiphyseal Dysplasia Tarda. Dr. Smith is currently accepting new patients.
Pediatric Faculty Foundation Inc
Joel Charrow is a Medical Genetics specialist and a Pediatrics provider in Chicago, Illinois. Dr. Charrow and is rated as an Advanced provider by MediFind in the treatment of Chondrodystrophy. His top areas of expertise are Gaucher Disease Type 1, Gaucher Disease, Achondroplasia, Pompe Disease, and Splenectomy.
Pediatric Faculty Foundation Inc
Priya Verghese is a Pediatrics specialist and a Nephrologist in Chicago, Illinois. Dr. Verghese and is rated as an Experienced provider by MediFind in the treatment of Chondrodystrophy. Her top areas of expertise are Chronic Kidney Disease, Focal Segmental Glomerulosclerosis, Cytomegalic Inclusion Disease, Kidney Transplant, and Tissue Biopsy.
Summary: Osteogenesis Imperfecta-related hearing loss usually occurs in individuals with mild (type I) OI and is much earlier in onset than age-related hearing loss, with the majority of individuals experiencing some minor hearing loss in their 20s. Bisphosphonates have been successfully used to treat otosclerosis, a common cause of hearing loss similar to OI-related hearing loss. As many individuals with ...
Summary: This is a long-term, multi-center, observational study in children 2.5 to \<17 years with achondroplasia (ACH). The objective is to evaluate growth, ACH-related medical complications, assessments of health-related quality of life, body pain, functional abilities, cognitive functions, and treatments of study participants. No study medication will be administered.